Care Health

Healthcare & Insurance

GLP-1 Medications and Weight Loss Research

In just the last few years, GLP-1s have revolutionized the treatment possibilities for obesity. Today, individuals have more options for controlling their weight than ever before. GLP-1 prescription medications work to regulate hunger signaling in the brain, help people feel full longer, and support long-term weight management goals.

There’s still a lot to learn, which is why weight loss clinical trials are still being done.

What GLP-1 Medications Actually Do

The body has a natural hormone that’s released after eating, called a peptide. This hormone regulates blood sugar and brain signaling involved in hunger. GLP-1, is a synthetic version of that same hormone. It works to increase the release of the hormone insulin when blood sugar is rising, lowers glucagon secretion and causes the stomach to take a longer time to empty.

The results? Longer feelings of satiety, fewer hunger cravings, and feeling full with smaller portions.

Overall, GLP-1s help a person lose weight by ingesting fewer calories. In turn, this lowers the risk of diabetes developing, and decreases the chances of heart disease, two of the highest risks associated with obesity.

The Differences Between Semaglutide and Tirzepatide

Semaglutide and tirzepatide are two similar, but different GLP-1s, and it’s helpful to understand how they work differently.

Semaglutide activates the GLP-1 receptor, only. It’s appropriate for adults struggling with obesity and for adults who aren’t quite obese but are a bit overweight and have a medical condition related to being overweight, such as diabetes. It’s also sometimes prescribed for obese kids aged 12 or older.

Tirzepatide acts not only on the GlP-1 receptor, but on the insulinotropic polypeptide, called GIP. So not only is the appetite regulated, but blood glucose is also regulated. This is typically prescribed for obese adults who not only struggle with being overweight, but also for related conditions like obstructive sleep apnea.

In direct comparisons, tirzepatide shows a larger average weight loss, but it really depends on the individual, since there are so many different factors that play into it.

Who Qualifies For Treatment?

All GLP-1 medications require a prescription, and that prescription relies on an evaluation by a licensed provider. Before approving anyone for GLP-1 medication, a provider will conduct a medical assessment that will consist of a health history questionnaire. Questions will include what current medications are being taken, what previous weight-management efforts have been made, and more. If necessary, a physical assessment may be done, where BMI would be measured.

BMI, or body mass index, would be 30 or higher to be considered obese. But a person with a BMI of 27 or higher, along with a weight-related medical condition, would also qualify.

Benefits, Side Effects, and Limitations

Of course, the biggest benefit to GLP-1s is the amount of weight that can be lost. For those who’ve been battling their weight for years, this can feel like the miracle they’ve been hoping for their whole lives. This weight loss has tremendous impact on physical, social, and emotional aspects. Patients often report things like more energy, more mental clarity, and having a more positive outlook on life. But there are also hidden benefits.

The loss of weight often results in better “numbers.” Lowered bad cholesterol, healthier blood pressure, lowered blood sugar, and more. All of this certainly gives credence to the idea of GLP-1s.

Like other medications, GLP-1s carry inherent risks. Because of the way these meds work, digestive symptoms are quite common. Patients report nausea, vomiting, constipation, diarrhea, acid reflux, cramping, and other unpleasantries. All of these should be reported to the provider, even if they seem mild in nature or of little significance.

There can also be serious side effects, which may necessitate the need for an emergency room visit. Gall bladder disease, pancreatitis, kidney malfunction, severe digestive upset; they’re all listed on the warning labels. For anyone with a personal or family history of certain cancers, there are heightened risks.

Note that GLP-1’s are not intended for short-term weight loss, like dropping 10 pounds to fit into a wedding gown, or losing weight before a beach vacation. They’re prescriptive for a reason: to help people who are obese or overweight plus a medical condition to reach a healthier weight over the long-term.

Long-term Treatment and Regaining Weight

Obesity is a chronic condition. That means it has a way of returning after weight loss. Research has shown that people tend to regain weight after they stop taking their GLP-1 medication, at least to some extent. This is why it’s considered a long-term solution.

At times, a person may need to cease taking their GLP-1 medication. Maybe they’ve become pregnant, can’t afford it any longer, no longer wish to live with the side effects, or something else. For whatever reason, it’s not a critical health risk to stop taking GLP-1. But because regaining the weight is a distinct possibility, it’s smart to consult with a provider. There are other treatments available to support weight management aside from GLP-1s. A person may avail of nutrition support, an exercise plan, community support apps, etc. Just because a person stops taking a GLP-1 doesn’t mean they should give up on being a healthy weight.

Comparing GLP-1 Medication With Other Treatments

Other treatment options for weight loss exist. Some may feel like a better fit than GLP-1s. They all work differently. Some are other kinds of medications that affect appetite signaling in the brain. Others reduce fat absorption.

You can also consider nutrition and physical activity programs. The results may not be as fast as with GLP-1s, but they have lower barriers to entry as far as not needing a prescription and costing little or no money.

There are also medical interventions, like bariatric surgery or endoscopic surgery. These are all worth learning more about and speaking to your doctor to learn more about your options.

New Medications and Clinical Research

The range of treatment options is expanding. In April 2026, the FDA approved orforglipron (Foundayo), an oral GLP-1 medication for chronic weight management in eligible adults. It’s taken once daily, providing an option for people who prefer a tablet to an injection. Its approval reflects continuing development of medicines that target appetite and metabolic regulation.

Researchers are also studying retatrutide, an investigational medicine that activates GIP, GLP-1, and glucagon receptors. It remains in Phase 3 trials and is not FDA-approved. Products sold outside legitimate clinical research should be avoided. Other studies examine new combinations, dosing approaches, and treatments for obesity-related conditions. Trials must establish long-term safety and effectiveness.

Finding and Evaluating a Clinical Trial

People interested in research can search clinicaltrials.gov for studies involving obesity, weight management, semaglutide, tirzepatide, or investigational medicines. Trial listings describe the study purpose, location, recruitment status, and eligibility criteria. A listing does not mean a study is suitable for every applicant or that the treatment is proven.

Prospective participants should review study details with a healthcare professional and contact the research team. Eligibility may depend on age, BMI, medical history, current medications, and previous treatment. Questions should cover risks, required visits, costs, placebo use, and follow-up care.

GLP-1-based treatments have expanded medical weight management. Their benefits can be substantial, but treatment requires screening, monitoring, and realistic expectations. Individuals should understand each medication’s approved uses, limitations, and potential need for long-term care.

Care Health

©Clinical Media. All rights reserved.

Do not sell my personal info